Gilead Sciences, Inc.
Holdings as of Jun 30, 2026 · filed Aug 3, 2026
| # | Holding | Value | % Port. | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Arcus Biosciences Inc. | $968825351 | 58.76% | — | Held |
| 2 | Lakefront Biotherapeutics | $500157715 | 30.34% | — | Held |
| 3 | Assembly Biosciences Inc. | $136770406 | 8.30% | +471698 | +10.47% |
| 4 | Kyverna Therapeutics Inc. | $36763720 | 2.23% | — | Held |
| 5 | Xilio Therapeutics Inc. | $6230727 | 0.38% | — | Held |
Closed last quarter
Arcellx Inc
Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.